Effects of early oral feeding after radical total gastrectomy in gastric cancer patients

Table 2 Baseline data of the two groups

Baseline data	EOF group, n = 105	Control group, n = 101	t value	P value
Gender, male/female, n	88/17	86/15	0.005	0.942
Age, yr	61.69 ± 10.80	61.36 ± 11.72	1.387	0.167
BMI, kg/m2	22.86 ± 4.70	23.15 ± 4.32	-0.797	0.426
NRS-2002 score , < 3 or ≥ 3, n	41/64	38/63	0.034	0.872
Preoperative serum PALB, mg/L	227.50 ± 28.20	225.41 ± 23.60	1.269	0.264
Preoperative serum ALB, g/L	39.24 ± 4.36	38.58 ± 3.85	1.833	0.076
Preoperative serum gastrin, ng/L	212.40 ± 57.50	211.70 ± 53.80	1.512	0.134
Preoperative serum motilin, ng/L	358.40 ± 67.10	360.20 ± 68.70	-1.946	0.071
Operating time, min	228.70 ± 31.20	225.90 ± 29.47	1.228	0.219
Blood loss, mL	155.68 ± 51.35	152.85 ± 52.46	1.294	0.211
Pathological stage, n (%)			0.014	0.913
Stage I	13 (12.38)	11 (10.89)
Stage II	48 (45.71)	45 (44.55)
Stage III	44 (41.91)	45 (44.55)
Differentiation, n (%)			0.008	0.930
Poor	52 (49.52)	33 (49.25)
Moderate	36 (34.29)	23 (34.33)
Well	17 (16.19)	11 (16.42)
Borrmann types, n (%)			0.221	0.694
I	8 (7.62)	9 (8.91)
II	34 (32.38)	33 (32.67)
III	47 (44.76)	45 (44.56)
IV	16 (15.24)	14 (13.86)
Lauren types, n (%)			0.675	0.407
Intestinal type	81 (77.14)	74 (73.27)
Diffuse type	24 (22.86)	27 (26.73)

EOF: Early oral feeding; BMI: Body mass index; NRS: Nutritional risk screening; PALB: Prealbumin; ALB: Albumin.